Main Menu
Untitled Page
Home > Equity > Company info > Company Snapshot
24 February 2018

Search Quotes

  Enter at least 3 characters from BSE Code for a company or the company's name

Sun Pharmaceuticals Industries Ltd (Pharmaceuticals - Indian - Bulk Drugs & Formln)

Last Price 569.65
Net Changes 28.20
Volume 30844893
Prev Close 541.45
569.65 28.20 (5.21%)
Date: Feb 23,2018 EOD




Index Details Pharmaceuticals - Indian - Bulk Drugs & Formln


Chart

Stock Price Details

Market Statistics

Open Price 550 Div Yield (%) 0.61
Buy (Size) 0.00(×0) Eps(Rs) 1.55
Sell (Size) 0.00(×0) Book Value(Rs) 81.1537707
Buy Quantity 0 Market Cap(Rs.Cr) 136809.41
Sell Quantity 0 Face Value(Rs) 1
Today's High 575 Market Lot 1
Today's Low 546.2 AGM Date Sep
52-Week High 728.45 Book Closure Date Sep
52-Week Low 433.15 ISIN No. INE044A01036

Share Holding Pattern

  No Of shares % Share Holding
Total Foreign (Promoter & Group) 0 0.00
Indian (Promoter & Group) 1304855381 54.38
Total of Promoter 1304855381 54.38
Non Promoter (Institution) 770948210 32.13
Non Promoter (Non-Institution) 323505755 13.48
Total Non Promoter 1094453965 45.62
Total Promoter & Non Promoter 2399309346 100.00
Custodians(Against Depository Receipts) 0 0.00
Grand Total 2399309346 100.00

Company News

22-Feb-2018  Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31...
Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jayant S Sanghvi
21-Feb-2018  SJVN Ltd leads losers in 'A' group
SJVN Ltd leads losers in 'A' group

Sun Pharmaceuticals Industries Ltd, Astra Microwave Products Ltd, Religare Enterprises Ltd and Oil India Ltd are among the other losers in the BSE's 'A' group today, 21 February 2018.

SJVN Ltd tumbled 6.28% to Rs 35.1 at 14:51 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 92590 shares were traded on the counter so far as against the average daily volumes of 1.26 lakh shares in the past one month.

Sun Pharmaceuticals Industries Ltd crashed 5.76% to Rs 527.2. The stock was the second biggest loser in 'A' group.On the BSE, 39.89 lakh shares were traded on the counter so far as against the average daily volumes of 7.79 lakh shares in the past one month.

Astra Microwave Products Ltd lost 5.08% to Rs 90.7. The stock was the third biggest loser in 'A' group.On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 91573 shares in the past one month.

Religare Enterprises Ltd shed 5.00% to Rs 57. The stock was the fourth biggest loser in 'A' group.On the BSE, 5.03 lakh shares were traded on the counter so far as against the average daily volumes of 12.91 lakh shares in the past one month.

Oil India Ltd fell 4.63% to Rs 344.85. The stock was the fifth biggest loser in 'A' group.On the BSE, 1.55 lakh shares were traded on the counter so far as against the average daily volumes of 56654 shares in the past one month.

20-Feb-2018  Sun Pharmaceutical Industries Limited - Updates
Sun Pharmaceutical Industries Limited - Updates

Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
20-Feb-2018  Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Indust...
Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Updates

Sun Pharmaceutical Industries Limited - Updates
19-Feb-2018  Sun Pharmaceuticals Industries Ltd - Announcement under Regula...
Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Updates on Acquisition

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
15-Feb-2018  Sun Pharma slips after weak Q3 earnings
Sun Pharma slips after weak Q3 earnings

The results were announced after market hours yesterday, 14 February 2018.

Meanwhile, the S&P BSE Sensex was up 144.86 points, or 0.42% to 34,300.81.

On the BSE, 34,000 shares were traded in the counter so far compared with average daily volumes of 5.41 lakh shares in the past one quarter. The stock had hit a high of Rs 581.10 and a low of Rs 564.50 so far during the day. The stock hit a 52-week high of Rs 728.45 on 14 March 2017. The stock hit a 52-week low of Rs 433.15 on 14 August 2017.

The stock had outperformed the market over the past 30 days till 14 February 2018, falling 0.63% compared with 1.77% fall in the Sensex. The scrip had also outperformed the market in past one quarter, rising 12.94% as against Sensex's 3.17% rise. The scrip had underperformed the market in past one year, falling 7.72% as against Sensex's 21.31% rise.

The large-cap company has equity capital of Rs 239.93 crore. Face value per share is Re 1.

Sun Pharmaceutical Industries (Sun Pharma)'s bottom line in Q3 December 2017 was adversely impacted by one-time deferred tax adjustment of Rs 513 crore related to changes in US tax rates.

Dilip Shanghvi, Managing Director, Sun Pharma, said that the company's Q3 performance reflects a gradual improvement in profitability over the first half of this year, despite a challenging US generic pricing environment. Sun Pharma will continue to evaluate opportunities in the specialty segment to further enhance this business, he said.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

15-Feb-2018  Sun Pharmaceuticals Industries reports standalone net profit o...
Sun Pharmaceuticals Industries reports standalone net profit of Rs 40.50 crore in the December 2017 quarter

Net profit of Sun Pharmaceuticals Industries reported to Rs 40.50 crore in the quarter ended December 2017 as against net loss of Rs 158.34 crore during the previous quarter ended December 2016. Sales rose 6.84% to Rs 1991.98 crore in the quarter ended December 2017 as against Rs 1864.45 crore during the previous quarter ended December 2016.

ParticularsQuarter Ended
 Dec. 2017Dec. 2016% Var.
Sales1991.981864.45 7
OPM %8.95-0.65 -
PBDT147.09-48.36 LP
PBT41.04-152.98 LP
NP40.50-158.34 LP
15-Feb-2018  Sun Pharmaceuticals Industries consolidated net profit decline...
Sun Pharmaceuticals Industries consolidated net profit declines 76.76% in the December 2017 quarter

Net profit of Sun Pharmaceuticals Industries declined 76.76% to Rs 400.17 crore in the quarter ended December 2017 as against Rs 1721.85 crore during the previous quarter ended December 2016. Sales declined 14.12% to Rs 6598.21 crore in the quarter ended December 2017 as against Rs 7683.24 crore during the previous quarter ended December 2016.

ParticularsQuarter Ended
 Dec. 2017Dec. 2016% Var.
Sales6598.217683.24 -14
OPM %22.0331.93 -
PBDT1487.242408.81 -38
PBT1147.922102.01 -45
NP400.171721.85 -77
15-Feb-2018  Sun Pharmaceutical Industries Limited - Press Release
Sun Pharmaceutical Industries Limited - Press Release

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated February 14, 2018, titled 'Sun Pharma reports Q3FY18 results'.
15-Feb-2018  Sun Pharmaceutical Industries Limited - Allotment of ESOP/ESPS
Sun Pharmaceutical Industries Limited - Allotment of ESOP/ESPS

Sun Pharmaceutical Industries Limited has informed the Exchange regarding allotment of 13834 Equity Shares under ESOP
Incorporation Year 1993 
Registered Office Sun Pharma Advanced Res.Centre,Tandalja,
Vadodara,
Gujarat-390020
Telephone 91-265-6615500 
Fax 91-265-2354897 
Chairman Israel Makov
Managing Director Dilip S Shanghvi
Company Secretary Sunil R Ajmera 
Auditor Deloitte Haskins & Sells/S R B C & Co LLP 
Face Value(Rs)
Market Lot
Listing MSEI,BSE,NSE 
Registrar Link Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083 
Toll Free number: 1800-425-5501 / 1800-103-5501
FINANCIAL TOOLS